Ana Monica is a Post-Doctoral Fellow in Formulation Division at CDRD. After graduating with a BSc/MSc in Technological Chemistry from the University of Lisbon (Portugal), she earned a PhD degree in Bioinorganic Chemistry at the University of Ioannina (Greece), where she elucidated a mechanism of metal toxicity and carcinogenesis.
She then joined Rutgers University (USA), as a post-doctoral researcher in Structural Biology. Using molecular biology and biophysical techniques, she obtained atomic level understanding on the mechanisms that regulate the interaction of collagen with cellular integrin receptors. The relevance of her work on platelet adhesion (and clot formation) awarded her with an American Heart Association Postdoctoral Fellowship. Later on, as research associate, she worked in projects related protein aggregation, investigating molecular structure-aggregation relationships of beta-2-microglobulin and synuclein proteins involved in dialysis-related amyloidosis (DRA) and Parkinson disease.
Her goal as a member of CDRD team is to help bring the next-generation therapeutics to patients while expanding her knowledge on drug discovery and development, in particular in drug formulations.